AU2001270082A1 - Gene markers for lung cancer - Google Patents

Gene markers for lung cancer

Info

Publication number
AU2001270082A1
AU2001270082A1 AU2001270082A AU7008201A AU2001270082A1 AU 2001270082 A1 AU2001270082 A1 AU 2001270082A1 AU 2001270082 A AU2001270082 A AU 2001270082A AU 7008201 A AU7008201 A AU 7008201A AU 2001270082 A1 AU2001270082 A1 AU 2001270082A1
Authority
AU
Australia
Prior art keywords
lung cancer
gene markers
markers
gene
lung
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001270082A
Inventor
Hideki Kambara
Masafumi Kawamura
Hiroko Matsunaga
Masato Mitsuhashi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hitachi Ltd
Showa Denko Materials Co Ltd
Showa Denko Materials America Inc
Original Assignee
Hitachi Chemical Co Ltd
Hitachi Ltd
Hitachi Chemical Research Center Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hitachi Chemical Co Ltd, Hitachi Ltd, Hitachi Chemical Research Center Inc filed Critical Hitachi Chemical Co Ltd
Publication of AU2001270082A1 publication Critical patent/AU2001270082A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57423—Specifically defined cancers of lung
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/686—Polymerase chain reaction [PCR]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
AU2001270082A 2000-06-21 2001-06-21 Gene markers for lung cancer Abandoned AU2001270082A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US21572700P 2000-06-21 2000-06-21
US60/215,727 2000-06-21
US24397600P 2000-10-27 2000-10-27
US60/243,976 2000-10-27
PCT/US2001/019980 WO2001098539A2 (en) 2000-06-21 2001-06-21 Gene markers for lung cancer

Publications (1)

Publication Number Publication Date
AU2001270082A1 true AU2001270082A1 (en) 2002-01-02

Family

ID=26910326

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001270082A Abandoned AU2001270082A1 (en) 2000-06-21 2001-06-21 Gene markers for lung cancer

Country Status (6)

Country Link
US (2) US7214781B2 (en)
EP (1) EP1356093A2 (en)
JP (1) JP4392163B2 (en)
CN (1) CN1471587A (en)
AU (1) AU2001270082A1 (en)
WO (1) WO2001098539A2 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2442993C (en) 2001-04-10 2011-10-11 Agensys, Inc. Nucleic acid and corresponding protein entitled 158p3d2 useful in treatment and detection of cancer
US8076080B2 (en) 2002-05-21 2011-12-13 Sysmex Corporation Nucleic acid amplification primers for detecting cytokeratins and examination method with the use of the primers
GB0215509D0 (en) * 2002-07-04 2002-08-14 Novartis Ag Marker genes
US20050186215A1 (en) * 2004-02-04 2005-08-25 Kwok Tim T. CUDR as biomarker for cancer progression and therapeutic response
AU2006281569A1 (en) 2005-08-17 2007-02-22 Medexis S.A. Composition and method for determination of CK19 expression
AU2006337636B2 (en) * 2006-02-03 2011-02-10 Hill's Pet Nutrition, Inc. Method for evaluating kidney function in a feline by measuring ghrelin hormone levels
EP2013366B1 (en) * 2006-05-01 2016-11-30 Siemens Healthcare Diagnostics Inc. Sequencing of the L10 codon of the HIV gag gene
KR101443214B1 (en) 2007-01-09 2014-09-24 삼성전자주식회사 A composition, kit and microarray for diagnosing the risk of lung cancer recurrence in a patient after lung cancer treatment or a lung cancer patient
WO2009043115A1 (en) * 2007-10-04 2009-04-09 Fermiscan Australia Pty Limited Method for identifying biomarkers which are diagnostic for a pathological condition
JP2013099253A (en) * 2010-03-11 2013-05-23 Intec Systems Institute Inc Diagnostic marker for lung cancer or cervical cancer
WO2012031374A1 (en) 2010-09-09 2012-03-15 北京同为时代生物技术有限公司 Blood markers for diagnosing epithelium derived cancers and monoclonal antibodies thereof
EP3467124A1 (en) * 2012-06-06 2019-04-10 Fundació Institut de Recerca Biomèdica IRB (Barcelona) Method for the diagnosis, prognosis and treatment of lung cancer metastasis
CN111183157A (en) 2017-10-02 2020-05-19 威特拉公司 CD138 antibody molecules and uses thereof
WO2020007898A1 (en) * 2018-07-04 2020-01-09 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and compositions for treating brain injury or neurodegenerative disease
US20200392241A1 (en) * 2019-06-17 2020-12-17 Visterra, Inc. Humanized antibody molecules to cd138 and uses thereof
KR20210020417A (en) * 2019-08-14 2021-02-24 연세대학교 산학협력단 Method for diagnosing lung cancer using methionyl-tRNA synthetase and pan-cytokeratin

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5272057A (en) 1988-10-14 1993-12-21 Georgetown University Method of detecting a predisposition to cancer by the use of restriction fragment length polymorphism of the gene for human poly (ADP-ribose) polymerase
AU3094999A (en) 1998-03-18 1999-10-11 Corixa Corporation Compounds and methods for therapy and diagnosis of lung cancer

Also Published As

Publication number Publication date
WO2001098539A3 (en) 2003-08-14
EP1356093A2 (en) 2003-10-29
JP4392163B2 (en) 2009-12-24
US7214781B2 (en) 2007-05-08
US20060275783A1 (en) 2006-12-07
WO2001098539A2 (en) 2001-12-27
CN1471587A (en) 2004-01-28
US20030215828A1 (en) 2003-11-20
JP2004500895A (en) 2004-01-15

Similar Documents

Publication Publication Date Title
AU2001292802A1 (en) Genetic markers for tumors
AU2002361908A1 (en) Methods for identifying marker genes for cancer
AU2003240495A1 (en) Diagnostics markers for lung cancer
AU2002351828A1 (en) Novel genetic markers for leukemias
AU2003294828A1 (en) Specific markers for pancreatic cancer
AU2002247304A1 (en) Anti-neovasculature preparations for cancer
AU2001270082A1 (en) Gene markers for lung cancer
AU2002360345A1 (en) Prostate cancer genes
AU2003204331A1 (en) Gene Encoding Labyrinthin, A Marker For Cancer
EP1314948A1 (en) Paintball markers
AU2001242625A1 (en) Gene sequence
AU2001282149A1 (en) Improved marker
AU2001264247A1 (en) GASC1 gene
AUPQ901700A0 (en) Molecular markers
AU2001295777A1 (en) Target
AUPQ749100A0 (en) New epilespy gene
AU2001285743A1 (en) Adipose-related gene
AU2001279630A1 (en) Tumor activated prodrug compounds
AU2001231192A1 (en) Mob-5/hmob-5 as a cancer diagnostic marker
AUPQ980600A0 (en) Tumour suppressor gene
AU2002228190A1 (en) Marker for roscovitine
AU6017900A (en) Novel tumor suppressor gene
AU2001255129A1 (en) Molecular markers
AU2001238143A1 (en) Tumor suppressor gene, p47ing3
AU6167200A (en) Selectable marker gene